| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/30/2013 | CA2422774C Remedies for amyotrophic lateral sclerosis |
| 07/25/2013 | WO2013109983A1 High molecular wieght arginine-grafted bioreducible polymers |
| 07/25/2013 | WO2013109876A1 Enhanced glycemic control using ad36e4orf1 and akt1 inhibitor |
| 07/25/2013 | WO2013107413A1 Use of phosphorylation pathway-related factor in regulating function of regulatory t cell |
| 07/25/2013 | WO2013078199A3 Methods for enhanced in vivo delivery of synthetic, modified rnas |
| 07/25/2013 | US20130190391 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130189225 Methods of increasing efficiency of vector penetration of target tissue |
| 07/25/2013 | US20130189189 COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF DISEASES RELATED TO CELLS EXPRESSING IL-8 OR GRO-ALPHA, COMPRISING UCB-MSCs |
| 07/24/2013 | EP2618147A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention |
| 07/24/2013 | EP2617823A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617822A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617821A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617820A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617819A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617818A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617817A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617816A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617815A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617814A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617729A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617728A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/24/2013 | EP2617435A1 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants |
| 07/24/2013 | EP2617426A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN1705740B Adenovirus expressing genes in reverse order and use thereof |
| 07/24/2013 | CN1462191B Treatment of ocute coronary syndrome with GLP-1 |
| 07/24/2013 | CN103221060A Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 07/24/2013 | CN103215351A In vitro cancer therapy compound identification method |
| 07/24/2013 | CN103215345A Host relative gene for inhibiting replication of influenza virus, screening method and application |
| 07/24/2013 | CN103215273A Protein CGREF1 inhibiting cell proliferation, and expression sequence and application thereof |
| 07/24/2013 | CN103215270A DNA (deoxyribonucleic acid) segment with function of inhibiting cell migration and invasion of glioma, and application of DNA segment |
| 07/24/2013 | CN103215269A Dsrna for treating viral infection |
| 07/24/2013 | CN103215268A Human fascin-1 gene siRNA and applications thereof |
| 07/24/2013 | CN103215267A siRNA for inhibiting influenza virus-related gene and application |
| 07/24/2013 | CN103215256A Polynucleotide having tumor cell inhibition function |
| 07/24/2013 | CN103215234A Adenovirus with zinc finger nuclease expression element and donor DNA, and construction method and application |
| 07/24/2013 | CN103215216A Melanoma therapeutic plasmid DNA (deoxyribonucleic acid) vaccine pSVK-CAVA preparation method as well as dedicated engineering bacterium and fermentation culture medium thereof |
| 07/24/2013 | CN103214672A Low molecular weight polyetherimide (PEI) derivative, preparation method and application thereof |
| 07/24/2013 | CN103214582A Immunogenic fusion protein for tuberculosis and application of immunogenic fusion protein |
| 07/24/2013 | CN103213967A Magnetic water-soluble carbon nano tube as well as preparation method and application thereof |
| 07/24/2013 | CN103212090A Application of microvesicle containing TGF (transforming growth factor)-beta1 siRNA (small interfering Ribonucleic Acid) |
| 07/24/2013 | CN103212089A Preparation method and application of carbon nanomaterial-immunostimulatory sequence compound |
| 07/24/2013 | CN103212088A Antisense compounds targeted to connexins and methods of use thereof |
| 07/24/2013 | CN103212085A Molecules for targeting compounds to various selected organs or tissues |
| 07/24/2013 | CN103212077A Application of Erbin inhibitor in preparation of antitumor drug |
| 07/24/2013 | CN103212064A Application of phosphorylation-pathway-related factor in regulating regulatory T-cell function |
| 07/24/2013 | CN102533860B Foot and mouth disease vaccine and preparation method thereof |
| 07/24/2013 | CN102492095B Construction of bio-reducible efficient cation gene vectors taking polysaccharides as frameworks with ATRP (Atom Transfer Radical Polymerization) method |
| 07/24/2013 | CN102408488B Quaternary ammonium type cationic starch gene controlled release vector material and preparation method and application thereof |
| 07/24/2013 | CN102268454B Prostate specific membrane antigen (PSMA) recombinant adeno-associated virus vector and its construction method and use |
| 07/24/2013 | CN102258779B Sequential and repeated application of four or more HIV (human immunodeficiency virus) vector gene vaccines |
| 07/24/2013 | CN102218136B Anti-reovirus oral gene engineering vaccine and its preparation method |
| 07/24/2013 | CN102159709B New therapeutic agent for malignant mesothelioma and immunostimulant |
| 07/23/2013 | US8492534 Compositions and methods for treatment of prostate and other cancers |
| 07/23/2013 | US8492357 Micro-RNA mediated modulation of colony stimulating factors |
| 07/23/2013 | US8491885 Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells |
| 07/23/2013 | US8491884 Virus clearance of neoplastic cells from mixed cellular compositions |
| 07/23/2013 | CA2537793C Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 07/23/2013 | CA2514646C Factor viii polypeptide |
| 07/23/2013 | CA2471968C Immunostimulatory nucleic acids and use thereof |
| 07/23/2013 | CA2428114C Apolipoprotein analogues |
| 07/23/2013 | CA2357950C Therapeutic phosphodiesterase inhibitors |
| 07/23/2013 | CA2250835C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/18/2013 | WO2013106812A1 Personalized medicine for the prediction of therapy targeting the hedgehog pathway |
| 07/18/2013 | WO2013106774A1 Cancer-specific suicide gene for cell-based and gene therapy |
| 07/18/2013 | WO2013106766A2 THERAPEUTIC INDICATIONS OF miR-1291 |
| 07/18/2013 | WO2013106677A1 Isolated human lung progenitor cells and uses thereof |
| 07/18/2013 | WO2013106592A1 Antagonists of mir-196a |
| 07/18/2013 | WO2013106496A1 Methods and compositions for targeting agents into and across the blood-brain barrier |
| 07/18/2013 | WO2013073480A9 Cationic lipid having improved intracellular kinetics |
| 07/18/2013 | WO2013069016A3 Long lasting drug formulations |
| 07/18/2013 | WO2013061091A3 Cystic fibrosis treatment |
| 07/18/2013 | WO2013040517A3 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH |
| 07/18/2013 | WO2012067866A8 Multivalent vaccine for filariasis |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184332 Vectors Containing the Max Gene |
| 07/18/2013 | US20130183333 Induced activation in dendritic cells |
| 07/18/2013 | US20130183318 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 07/17/2013 | EP2615102A1 Promoter inducible by reactive oxygen species and vector comprising the same |
| 07/17/2013 | EP2614077A1 Chimeric antigen receptors with an optimized hinge region |
| 07/17/2013 | EP2613811A1 Use of a dna expression construct |
| 07/17/2013 | EP2613768A1 Novel gene vaccination liposomes |
| 07/17/2013 | CN1946421B Cancer treatment using viruses and camptothecins |
| 07/17/2013 | CN103210086A Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4 |
| 07/17/2013 | CN103209688A Particulate substances comprising ceramic particles for delivery of biomolecules |
| 07/17/2013 | CN103205488A Method and reagent for prediction of ankylosing spondylitis susceptibility |
| 07/17/2013 | CN103205487A Method and detection reagent for prediction of prostate cancer susceptibility |
| 07/17/2013 | CN103205486A Method and reagent for prediction of susceptibility of prostate cancer |
| 07/17/2013 | CN103205461A SiRNA expression vector and application thereof |
| 07/17/2013 | CN103205432A Disseminated superficial actinic porokeratosis (DSAP) related gene |
| 07/17/2013 | CN103205400A Recombinant lentiviral vector containing ubiquitin-specific protease gene USP39-shRNA (short hairpin ribonucleic acid) and application thereof |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103204920A Novel epidermal growth factors and applications for same |
| 07/17/2013 | CN103203028A Vaccine composition for improving immune protective rate of anti-Fasciola hepatica Cat L1 DNA, and preparation method thereof |
| 07/17/2013 | CN103203027A Methods And Compositions For The Treatment And Prevention Of Aging-associated Conditions |
| 07/17/2013 | CN103203026A The applications of gene Grp75 in the preparation of drugs for the treatment of liver fibrosis |
| 07/17/2013 | CN103203025A Application of gene modified mesenchymal stem cell in pulmonary fibrosis treatment |
| 07/17/2013 | CN102851293B Sequence siRNA-165 capable of targeted inhibition of capripoxvirus ORF095 gene |
| 07/17/2013 | CN102776235B Recombinant expression plasmid and application thereof in preparing anti-tumor immunogene therapeutic medicament |